GRP78 inhibitor (Georgetown University Medical Center)

N/A

Report date: 2025/03/20 15:18:04
NME

Base Information

Drug NameGRP78 inhibitor (Georgetown University Medical Center)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action78 kDa glucose-regulated protein inhibitors
Targets78 kDa glucose-regulated protein
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGeorgetown University Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesGeorgetown University Medical Center
Inactive CompaniesN/A
Active IndicationsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A